Immunosuppressive Effect of Leukotriene B4 Receptor Antagonist in Vitro
- 1 October 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 264 (2) , 321-326
- https://doi.org/10.1006/bbrc.1999.1523
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Diacylglycerol lipase activation and 5‐lipoxygenase activation and translocation following TCR/CD3 triggering in T cellsEuropean Journal of Immunology, 1995
- ONO-4057, a novel, orally active leukotriene B4 antagonist: Effects on LTB4-induced neutrophil functionsProstaglandins, 1992
- THE IMMUNOSUPPRESSIVE PROPERTIES OF ENISOPROST AND A 5-LIPOXYGENASE INHIBITOR (SC-45662)Transplantation, 1991
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Chemotactic Activity of LTB4 in ManAllergy, 1986
- Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.Journal of Clinical Investigation, 1986
- Immunoregulation by leukotrienes and other lipoxygenase metabolitesImmunology Today, 1985
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.Journal of Clinical Investigation, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.Proceedings of the National Academy of Sciences, 1981